1.
Made by @hupertan
New article: Pollen and Vitamin in chronic
prostatitis/chronic pelvic pain syndrome.
Commented and cured Vincent
@Hupertan
Tags: chronic pelvic pain syndrome, chronic prostatitis, #chronicprostatitis,
#pollen extract; #prostatitis syndrome; #prostatitissyndrome, #qualityoflife

2.
Made by @hupertan
• Vincent Hupertan (the "Author”) is an independent blogger, with many social
media accounts, including Twitter (hupertan), Linkedin (Hupertan), Google+
(+ DrHupertan), Facebook (DrVHupertan), Wordpress (Hupertan) ,
SlideShare, etc
• Is otherwise hospital doctor, registered in the Council of the College of
Physician Paris with RPPS number: 1000 39 70 315 and Order No: 75 1
68044 8. His acitivity as author, blogger, tweeter is fully exercised privately.
• The document whose content Hupertan Vincent is the author and the
information contained therein are provided by the author for educational
purposes and are not intended to provide medical advice.
• You acknowledge your understanding that the site should not be used as a
substitute for a notice of by a health professional accredited to your country.
• By accessing the following slides, you understand and acknowledge that
there is no physician-patient relationship between you and the author. More
information's here
http://www.pearltrees.com/hupertan/11-web-responsabilite-medicale/
id11903422/item123273777

3.
Made by @hupertan
Pollen extract in association with vitamins provides early pain relief in patients affected by chronic
prostatitis/chronic pelvic pain syndrome.
Cai T1, Wagenlehner FM2, Luciani LG1, Tiscione D1, Malossini G1, Verze P3, Mirone V3, Bartoletti R4.
Exp Ther Med. 2014 Oct;8(4):1032-1038. Epub 2014 Jul 24.
Abstract
The therapeutic efficacy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is currently
unsatisfactory. The aim of the present study was to assess the safety and efficacy of pollen extract in
association with vitamins (DEPROX 500®) in males with CP/CPPS. All patients with a diagnosis of
CP/CPPS attending the same urologic centre between March and October 2012 were enrolled in this
randomised controlled phase III study. Participants were randomised to receive oral capsules of DEPROX
500® (two capsules every 24 h) or ibuprofen (600 mg, one tablet three times a day) for four weeks. The
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), International Prostate
Symptom Score and Quality of Well-Being (QoL) questionnaires were used. In the intention-to-treat
analysis, 87 males (25 class IIIa and 62 class IIIb) with a mean age of 33.6±5.9 years were randomly
allocated to the DEPROX 500® (n=41) or ibuprofen (n=46) treatment groups. At the follow-up
examination (following one month of treatment), in the DEPROX 500® group, 31/41 patients (75.6%)
reported an improvement in quality of life, defined as a reduction of the NIH-CPSI total score by ≥25%,
compared with 19/46 (41.3%) in the control group (P=0.002). The greater improvement in the DEPROX
500® group compared with the ibuprofen group was statistically significant (treatment difference in the
NIH-CPSI pain domain, -2.14±0.51, P<0.001; QoL scores, P=0.002). All patients were negative at the
Meares-Stamey test evaluation. Adverse events were less frequent in the DEPROX 500® group than in
the ibuprofen group. The DEPROX 500® treatment significantly improved total symptoms, pain and
quality of life compared with ibuprofen in patients with CP/CPPS, without severe side-effects.

4.
Made by @hupertan
RESULTS
DEPROX 500® group
QoL improvement -
76%
24%
Ibuprofen group (Control)
QoL improvement -
41%
59%
At the follow-up examination (following one month of treatment), in the DEPROX 500® group,
31/41 patients (75.6%) reported an improvement in quality of life, defined as a reduction of the
NIH-CPSI total score by ≥25%, compared with 19/46 (41.3%) in the control group (P=0.002).

5.
Made by @hupertan
Comments by @hupertan
• Chronic syndrome of chronic prostatitis / pelvic pain (CP / CPPS) is a very
difficult to treat satisfactorily very complex disease, although some
patients respond to treatment;
• 3-As a rule: alpha blockers, antibiotics, anti-inflammatory, is not always
effective;
• Evaluation of Meares-Stamey test is often negative and antibiotics should
be considered with caution;
• Long treatment by anti-inflammayorees must be considered with caution
because of side effects;
• A number of studies have shown the effectiveness of pollen extract should
be taken into account and encourage large scale trials to test their
effectiveness.
• Nevertheless, in some patients, this treatment could be offered.

6.
Made by @hupertan
If you like this slide, please «Tweet» / «Like it» / «Pin it» /
«Share.it» with your friends, students, colleagues....